Should all patients with Hodgkin lymphoma who relapse after autologous SCT be considered for allogeneic SCT? by Karl S. Peggs

Get full text

Donor whole blood DNA methylation is not a strong predictor of acute graft versus host disease in unrelated donor allogeneic haematopoietic cell transplantation by Amy P. Webster, Amy P. Webster, Simone Ecker, Ismail Moghul, Xiaohong Liu, Pawan Dhami, Pawan Dhami, Sarah Marzi, Dirk S. Paul, Michelle Kuxhausen, Stephanie J. Lee, Stephanie J. Lee, Stephen R. Spellman, Tao Wang, Tao Wang, Andrew Feber, Andrew Feber, Vardhman Rakyan, Karl S. Peggs, Karl S. Peggs, Stephan Beck

Get full text

AKT inhibition generates potent polyfunctional clinical grade AUTO1 CAR T-cells, enhancing function and survival by Harry Dolstra, Claire Roddie, Martin A Pule, Vedika Mehra, Giulia Agliardi, Juliana Dias Alves Pinto, Manar S Shafat, Amaia Cadinanos Garai, Louisa Green, Alastair Hotblack, Fred Arce Vargas, Karl S Peggs, Anniek B van der Waart

Get full text

Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function by Maria M. Cuadrado, Richard M. Szydlo, Mike Watts, Nishil Patel, Hanna Renshaw, Jude Dorman, Mark Lowdell, Stuart Ings, Chloe Anthias, Alejandro Madrigal, Stephen Mackinnon, Panagiotis Kottaridis, Ben Carpenter, Rachael Hough, Emma Morris, Kirsty Thomson, Karl S. Peggs, Ronjon Chakraverty

Get full text

Allo-HSCT in transplant-naïve patients with Hodgkin lymphoma: a single-arm, multicenter study by Emma Das-Gupta, Kirsty J. Thomson, Adrian J.C. Bloor, Andrew D. Clark, Stephen Mackinnon, Irfan Kayani, Laura Clifton-Hadley, Pip Patrick, Nadjet El-Mehidi, Anthony Lawrie, Amy A. Kirkwood, Nigel H. Russell, David C. Linch, Karl S. Peggs

Get full text